Vaccines

Prophylactic and therapeutic vaccines including mRNA platforms, viral vectors, and nanoparticle-based approaches.

Companies

Pipeline Drugs

194

Key People

228

Vaccines Pipeline (194 drugs)

Phase 3: 35Commercial: 29Preclinical: 29Not Disclosed: 8Pre-clinical: 8Approved: 7Phase 1: 7Phase III: 6Development: 5Phase 1/2: 5Not Applicable (Service Provider): 5Phase 1-3: 5Launched: 4Phase 2: 3Unknown: 3Not Disclosed (Sponsor-led): 3Discovery: 2Phase 2b: 2Phase I/II: 2Marketed: 2Phase I: 2Phase III/Commercial: 1Commercial (Distribution): 1Research: 1Service: 1Phase 2 (planned): 1Varies by Sponsor Protocol: 1Preclinical/CMC Development: 1Pre‑launch: 1N/A: 1Phase 2b/3: 1Regulatory Review: 1Phase III / Marketed: 1Regulatory (EU): 1Approved (EU): 1NDA Submitted: 1Filed: 1Various: 1Research to Phase 3: 1Development/Launched: 1Preclinical/Discovery: 1Approved in China: 1Phase II: 1

Drug	Company	Indication	Phase	Status
Oncology/Immuno-oncology Portfolio	MSD	Various Cancers	Phase III/Commercial	Active
HIV Treatment Portfolio	MSD	HIV Infection	Commercial	Active
Vaccines Portfolio	MSD	Various Preventable Diseases	Commercial	Active
Novel Vaccines	MSD	Undisclosed	Development	Active
Undisclosed CNS Therapeutic	PassPort Technologies	Central Nervous System Disorder	Preclinical	Active
P-001	Panacea Biotec	Chronic Lymphocytic Leukemia	Phase 2	Active
P-002	Panacea Biotec	Advanced Solid Tumors	Phase 1/2	Active
P-003	Panacea Biotec	HER2‑Positive Breast Cancer	Phase 3	Active
P-004	Panacea Biotec	COVID‑19	Phase 3	Active
Recombinant FSH	Bharat Serums & Vaccines	Infertility	Commercial	Active
Recombinant HCG	Bharat Serums & Vaccines	Assisted Reproductive Therapy	Commercial	Active
Anti‑Rho(D) Monoclonal Antibody	Bharat Serums & Vaccines	Rh Incompatibility	Commercial	Active
Liposomal Amphotericin B	Bharat Serums & Vaccines	Fungal Infections	Commercial	Active
NexoBrid	Bharat Serums & Vaccines	Severe Burn Management	Commercial (Distribution)	Active
Anti‑Thymocyte Globulin	Bharat Serums & Vaccines	Organ Transplant Rejection	Commercial	Active
Abhayrab	Indian Immunologicals	Human Rabies	Approved	Active
Hepatitis A Vaccine	Indian Immunologicals	Human Hepatitis A	Approved	Active
Porcine Cysticercosis Vaccine	Indian Immunologicals	Porcine Cysticercosis	Approved	Active
gE‑Deleted DIVA Marker Vaccine	Indian Immunologicals	Infectious Bovine Rhinotritis (IBR)	Approved	Active
Bi‑valent Human Monoclonal Antibody for Rabies	Indian Immunologicals	Human Rabies Post‑Exposure Prophylaxis	Phase 1	Active
BETD	Biological E.	Diphtheria and Tetanus	Commercial	Active
Bett	Biological E.	Tetanus	Commercial	Active
BEVAC	Biological E.	Hepatitis B	Commercial	Active
COMBEFIVE	Biological E.	Pentavalent (DTwP‑rHepB‑Hib)	Commercial	Active
CORBEVAX	Biological E.	SARS‑CoV‑2 (COVID‑19)	Commercial	Active
HAPIBEV	Biological E.	Hepatitis A	Commercial	Active
HIBE	Biological E.	Haemophilus influenzae type b	Commercial	Active
JEEV	Biological E.	Japanese Encephalitis	Commercial	Active
MRBEV	Biological E.	Measles & Rubella	Commercial	Active
Pneubevax‑14	Biological E.	Pneumococcal Polysaccharide Conjugate	Commercial	Active
TRIPVAC	Biological E.	Diphtheria, Tetanus and Pertussis	Commercial	Active
TYPHIBEV	Biological E.	Typhoid Conjugate	Commercial	Active
Salt-Active Nucleases (SAN)	ArcticZymes Technologies	Downstream Processing of Viral Vectors, Vaccines, Biologics	Commercial	Active
COD UNG (Uracil-DNA Glycosylase)	ArcticZymes Technologies	Prevention of PCR carryover contamination	Commercial	Active
GMP-Grade Nucleases Portfolio	ArcticZymes Technologies	Host Cell DNA/RNA removal in cGMP manufacturing	Commercial	Active
Specialty Enzymes for Diagnostics	ArcticZymes Technologies	Components for IVD assay development	Commercial	Active
Pegfilgrastim	Epygen Biotech	Oncology (Neutropenia)	Not Disclosed	Active
Bevacizumab	Epygen Biotech	Oncology	Not Disclosed	Active
Recombinant Streptokinase	Epygen Biotech	Cardiovascular (Thrombolysis)	Not Disclosed	Active
Teriparatide	Epygen Biotech	Osteoporosis	Not Disclosed	Active
SARS-CoV-2 Vaccine	Epygen Biotech	COVID-19 Prevention	Not Disclosed	Active
Rhodococcus Equi Antibody Optimization	MG Biologics	Rhodococcus equi infection in foals	Research	Active
ImmunoGut	MG Biologics	Gastrointestinal support against E. coli, Parvovirus, Salmonella, C. difficile	Commercial	Active
Custom Blend Program	MG Biologics	Farm-specific pathogen combinations	Service	Active
Undisclosed Vaccine Enhancement Program	Qrono	Infectious Disease (unspecified)	Pre-clinical	Active
Undisclosed Autoimmune Therapy Program	Qrono	Autoimmune Disease (unspecified)	Pre-clinical	Active
Blepharitis Studies	Oculus Research	Blepharitis	Not Applicable (Service Provider)	Active
Dry Eye Studies	Oculus Research	Dry Eye Disease	Not Applicable (Service Provider)	Active
Glaucoma Studies	Oculus Research	Glaucoma/Ocular Hypertension	Not Applicable (Service Provider)	Active
Myopia Control Studies	Oculus Research	Myopia Control	Not Applicable (Service Provider)	Active